- Human Biospecimens
- For Researchers
- For Biospecimen Contributors
- For Patients
Lexington, MA, June 2, 2016 – iSpecimen®, a trusted source of customized human biospecimen collections, today announced the appointment of Eric Langlois to the position of Vice President of Sales and Business Development. In this role, Eric will be responsible for driving company sales as the firm offers a broader range of biospecimens to the scientific community, including biofluids, solid tissue, and viable cells, all paired with de-identified patient- and specimen-level data to meet researcher needs.
“As personalized medicine surges on biomedical research becomes more targeted, particularly at the molecular level,” said Chris Ianelli, MD, PhD, CEO, iSpecimen. “The life science field is exploding with opportunity to learn, to create, and to diagnose and treat disease. Data-rich human biospecimens are a critical piece in this process and with the evolving sets of researcher needs, as well as our expanded offerings, it was time to add a senior leader dedicated to the sales and business development effort. We are seeing increasingly complex requests, particularly for the latest techniques in cancer research, and because of this have also expanded our operations and laboratory staff. Eric is now working with them directly to ensure we are serving researchers as efficiently as we can, with customized procurement and outstanding service.”
With nearly 20 years of experience in sales and business development for preclinical sample collections in translational research, most recently as Head of North American Sales for the ReproCell Group, Eric is playing a key role not only in expanding the iSpecimen researcher customer base, but also in analyzing and developing the supply partner network in order to meet customer demands. iSpecimen launched the latest iteration of its technology last year, and the company continues to add a diverse range of supply partner sites to its network. Initially working with hospitals and commercial labs, iSpecimen’s network now also includes blood centers, biorepositories, Health Information Exchanges, Contract Research Organizations, and cancer centers.
“iSpecimen’s technology enables a more strategic and orderly form of specimen procurement,” said Eric. “The company’s cloud-based software was a critical reason for my joining the team. I’m excited to be part of a company that is leading change in the industry, and streamlining what has long been an arduous and quality-challenged process. I look forward to working with iSpecimen to continue advancing research.”
Privately held and headquartered in Lexington, Massachusetts, iSpecimen is a trusted, one-stop source of customized human biospecimen collections. Compliantly sourced from our diverse partner network of hospitals, labs, biorepositories, blood centers, and other organizations, our solid tissue, biofluids, and cells are delivered directly into the hands of researchers using unique, turnkey technology. Scientists gain access to a ready supply of the high-quality, richly-annotated biospecimens they need from the patients they want. Supply partners gain an opportunity to further contribute to biomedical discovery as well as their bottom line. And ultimately, healthcare advances for all. For more information about iSpecimen, please visit www.ispecimen.com.